Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pentosan polysulfate sodium - bene-Arzneimittel/ReqMed

Drug Profile

Pentosan polysulfate sodium - bene-Arzneimittel/ReqMed

Alternative Names: AK-150; Elmiron; NaPPS

Latest Information Update: 24 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator bene-Arzneimittel; ReqMed
  • Developer Asahi Kasei; Bayer; bene-Arzneimittel; Multiplex Pharma Holdings; Ortho-McNeil Pharmaceutical; Teva Pharmaceutical Industries
  • Class Analgesics; Anti-inflammatories; Antiallergics; Anticoagulants; Antihyperlipidaemics; Antiretrovirals; Antithrombotics; Antivirals; Glycosaminoglycans; Polymers; Polysaccharides; Small molecules; Sulfuric acids
  • Mechanism of Action Cell membrane permeability inhibitors; Non-nucleoside reverse transcriptase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pain; Interstitial cystitis
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Interstitial cystitis; Pain
  • Phase II Mucopolysaccharidosis I
  • Phase I/II Mucopolysaccharidosis VI
  • Discontinued Osteoarthritis; Spinal cord disorders

Most Recent Events

  • 13 Nov 2019 The National Institute for Health and Care Excellence (NICE) recommends use of pentosan polysulfate sodium for Interstitial cystitis in United Kingdom
  • 11 Nov 2019 Consilient Health announces intention to launch pentosan polysulfate sodium for Interstitial cystitis in Scotland
  • 11 Nov 2019 The Scottish Medicines Consortium recommends use of pentosan polysulfate sodium for Interstitial cystitis in Scotland
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top